Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Singular Genomics Systems, Inc./ 10-K

Annual Report · 10-K

Singular Genomics Systems, Inc.

Annual Report

Filed Mar 14, 2022Accepted Mar 14, 2022, 12:06 PM EDTCIK 1850906Accession 0000950170-22-003570
View company →Permanent SEC source ↗
Share

Recent company filings

  1. SCHEDULE 13G/A - filed by ARCH Venture Fund IX, L.P. regarding Singular Genomics Systems, Inc.May 15, 2025
  2. 8-K filingFeb 27, 2025
  3. SCHEDULE 13D/A - filed by Flynn James E regarding Singular Genomics Systems, Inc.Feb 25, 2025
  4. 4 filingFeb 25, 2025
  5. 4 filingFeb 25, 2025

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗